Category: Insights

To successfully commercialize orphan drugs, biopharma companies need to set aside general medicine strategies and adopt a more granular approach to identifying and capitalizing on commercial opportunities. In Pharmaceutical Executive, Dennis Fournogerakis, Esin Izat and Dan Wetherill describe how companies can start this process by transforming their forecasting efforts.

Digital promotion will remain a significant part of sales and marketing efforts and will significantly impact the makeup of sales teams in the pharma industry. In Med Ad News, Associate Partner Kevin Frymire explains what pharma companies should do to maximize the effectiveness of sales teams in a virtual world.

To succeed with personalized marketing, pharma companies must commit at the enterprise level and enable analytics, processes and platforms. How can pharmaceutical companies develop this enterprise commitment to personalized marketing in 2021? Vice President of Digital Strategy, Analytics, and Insights David Laros outlines four keys to success in a recent article with Med Ad News.

COVID-19 or not, proper data management remains a critical element of pharma companies’ commercial success. Associate Partner Justin Khalifa discusses with Med Ad News the importance of data management and how pharma companies must understand, plan and adapt to prevalent trends.

Debbie Rabishaw, head of HR, was recently named a Top 50 HR Professional by the OnCon Icon Awards. Award finalists are voted on by more than 10,000 peers to recognize the top HR professionals and vendors in the world.

Beghou Consulting’s new cloud-based forecasting platform, Mainsail™ Forecast, was named one of the most innovative products of 2020 by PM360 Magazine. The platform allows life sciences companies to perform complex calculations related to treatment regimens, patient flows, lines of therapy and more, resulting in a more robust, accurate forecast. Read more in PM360 magazine.

Patient compliance has become a more acute challenge during the coronavirus pandemic. In this article in Pharmaceutical Executive, Beghou Consulting Partner Dan Wetherill explains how biopharmaceutical companies can play a significant role in improving patient compliance by leveraging their advanced analytics capabilities and increasing collaboration with caregivers.

The coronavirus pandemic has limited patient visits to health care providers, interfered with treatment schedules and slowed down disease diagnoses. Vice President Janardhan Vellore explains in Pharmaceutical Commerce how biopharmaceutical companies can rethink their go-to-market strategies to reach patients and physicians using virtual selling and non-personal promotional tactics.